Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -140.43% is in line with its 5-year average of -150.44%, around the middle of its 5-year range (-302.05%–0.00%).
0.92% below its 12-month average of -139.15%.
Reported quarterly profit margin; no daily interpolation. Q1 FY2027 (2026-07-31): -142.35%.
NET PROFIT MARGIN
-140.43%
NET PROFIT MARGIN AVG TTM
-139.15%
NET PROFIT MARGIN AVG 3Y
-174.29%
NET PROFIT MARGIN AVG 5Y
-150.44%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-0.92%
CURRENT VS 3Y AVG
+19.43%
CURRENT VS 5Y AVG
+6.65%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 663 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Kestra Medical Technologies, Ltd.
Market Cap
$1.62B
Net Profit Margin
-140.43%
TTM Avg
-139.15%
3Y Avg
-174.29%
5Y Avg
-150.44%
Market Cap
$1.63B
Net Profit Margin
10.82%
TTM Avg
2.93%
3Y Avg
-1.36%
5Y Avg
-5.99%
Market Cap
$1.62B
Net Profit Margin
-579.10%
TTM Avg
-408.42%
3Y Avg
-273.23%
5Y Avg
-333.72%
Market Cap
$1.63B
Net Profit Margin
-13.50%
TTM Avg
-22.64%
3Y Avg
-31.77%
5Y Avg
-40.07%
Market Cap
$1.54B
Net Profit Margin
80.56%
TTM Avg
35.15%
3Y Avg
48.19%
5Y Avg
54.54%
Market Cap
$1.72B
Net Profit Margin
0.89%
TTM Avg
-2.38%
3Y Avg
-5.83%
5Y Avg
-7.07%
Market Cap
$1.72B
Net Profit Margin
-14.99%
TTM Avg
-20.12%
3Y Avg
-16.95%
5Y Avg
-10.04%
Market Cap
$1.53B
Net Profit Margin
21.25%
TTM Avg
9.48%
3Y Avg
-48.31%
5Y Avg
-19.09%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kestra Medical Technologies, Ltd. (KMTS) | $1.62B | -140.43% | -139.15% | -174.29% | -150.44% |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.63B | 10.82% | 2.93% | -1.36% | -5.99% |
| Ocular Therapeutix, Inc. (OCUL)vs › | $1.62B | -579.10% | -408.42% | -273.23% | -333.72% |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.63B | -13.50% | -22.64% | -31.77% | -40.07% |
| Omnicell, Inc. (OMCL)vs › | $1.58B | 3.13% | 0.65% | -0.01% | 1.74% |
| Innoviva, Inc. (INVA)vs › | $1.54B | 80.56% | 35.15% | 48.19% | 54.54% |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.72B | 0.89% | -2.38% | -5.83% | -7.07% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.72B | -14.99% | -20.12% | -16.95% | -10.04% |
| Nutex Health, Inc. (NUTX)vs › | $1.53B | 21.25% | 9.48% | -48.31% | -19.09% |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.51B | 12.02% | -7.78% | -15.24% | -11964.64% |
Operating Margin
-134.5%
Net Profit Margin
-140.4%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-07-31 | -142.35% |
| 2026-04-30 | -135.61% |
| 2026-01-31 | -139.16% |
| 2025-10-31 | -145.29% |
| 2025-07-31 | -133.32% |
| 2025-04-30 | -302.05% |
| 2025-01-31 | -142.54% |
| 2024-10-31 | -138.46% |
| 2024-07-31 | -155.56% |
| 2024-04-30 | -221.64% |
| 2024-01-31 | -261.19% |
| 2021-07-31 | 0.00% |
